Elevance Health Aktie 26124340 / US0367521038
409.96
USD
1.58
USD
0.39%
19:57:22
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Elevance Health Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Elevance Health Inc Registered Shs | 1.77 | 6.52 | USD |
| 2023 | Elevance Health Inc Registered Shs | 1.26 | 5.92 | USD |
| 2022 | Elevance Health Inc Registered Shs | 1.00 | 5.12 | USD |
| 2021 | Elevance Health Inc Registered Shs | 0.98 | 4.52 | USD |
| 2020 | Elevance Health Inc Registered Shs | 1.18 | 3.80 | USD |
| 2019 | Elevance Health Inc Registered Shs | 1.06 | 3.20 | USD |
| 2018 | Elevance Health Inc Registered Shs | 1.14 | 3.00 | USD |
| 2017 | Elevance Health Inc Registered Shs | 1.20 | 2.70 | USD |
| 2016 | Elevance Health Inc Registered Shs | 1.81 | 2.60 | USD |
| 2015 | Elevance Health Inc Registered Shs | 1.79 | 2.50 | USD |
Gewinn je Aktie- Elevance Health
| 25.7 24 | 25.2 23 | 24.8 22 | 24.7 21 | 18.0 20 | 18.5 19 | 14.2 18 |
Umsatz je Aktie- Elevance Health
| 759 24 | 722 23 | 645 22 | 562 21 | 479 20 | 400 19 | 349 18 |
KGV- Elevance Health
| 14.4 24 | 18.7 23 | 20.7 22 | 18.7 21 | 17.9 20 | 16.4 19 | 18.5 18 |
Elevance Health Inc Registered Shs: Die Aktie (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | 25.68 | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 |
| Gewinn je Aktie (unverwässert) | 25.81 | 25.38 | 25.10 | 25.04 | 18.23 | 18.81 | 14.53 |
| Gewinn je Aktie (verwässert) | 25.68 | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 |
| Dividende je Aktie | 6.52 | 5.92 | 5.12 | 4.52 | 3.80 | 3.20 | 3.00 |
| Veränderung Dividende je Aktie in % | 10.14 | 15.63 | 13.27 | 18.95 | 18.75 | 6.67 | 11.11 |
| Gesamtdividendenausschüttung in Mio. | 1’508.00 | 1’395.00 | 1’229.00 | 1’104.00 | 954.00 | 818.00 | 776.00 |
Elevance Health Inc Registered Shs: Unternehmenskennzahlen (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 759.17 | 721.74 | 644.95 | 561.75 | 479.23 | 400.36 | 348.62 |
| KGV (Jahresendkurs, Gewinn unverwässert) | 14.37 | 18.70 | 20.67 | 18.74 | 17.86 | 16.35 | 18.50 |
| KGV (Jahresendkurs, Gewinn verwässert) | 14.37 | 18.70 | 20.67 | 18.74 | 17.86 | 16.35 | 18.50 |
| Dividendenrendite Jahresende in % | 1.77 | 1.26 | 1.00 | 0.98 | 1.18 | 1.06 | 1.14 |
| Eigenkapitalquote in % | 35.44 | 36.18 | 35.41 | 37.07 | 37.61 | 40.54 | 39.38 |
| Fremdkapitalquote in % | 64.56 | 63.82 | 64.59 | 62.93 | 62.39 | 59.46 | 60.62 |
Elevance Health Inc Registered Shs: GuV (in Mio. USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 176’810.00 | 171’340.00 | 156’595.00 | 138’639.00 | 121’867.00 | 104’213.00 | 92’105.00 |
| Umsatzveränderung in % | 3.19 | 9.42 | 12.95 | 13.76 | 16.94 | 13.15 | 2.29 |
| Bruttoergebnis vom Umsatz | - | - | - | - | - | - | - |
| Bruttoergebnisveränderung in % | - | - | - | - | - | - | - |
| Operatives Ergebnis | 8’888.00 | 8’745.00 | 8’659.00 | 8’946.00 | 7’711.00 | 6’733.00 | 5’837.00 |
| Veränderung Operatives Ergebnis in % | 1.64 | 0.99 | -3.21 | 16.02 | 14.53 | 15.35 | 17.09 |
| Ergebnis vor Steuern | 7’904.00 | 7’715.00 | 7’769.00 | 7’925.00 | 6’238.00 | 5’985.00 | 5’068.00 |
| Veränderung Ergebnis vor Steuern in % | 2.45 | -0.70 | -1.97 | 27.04 | 4.23 | 18.09 | 27.86 |
| Ergebnis nach Steuer | 5’980.00 | 5’987.00 | 6’025.00 | 6’104.00 | 4’572.00 | 4’807.00 | 3’750.00 |
| Veränderung Ergebnis nach Steuer in % | -0.12 | -0.63 | -1.29 | 33.51 | -4.89 | 28.19 | -2.41 |
Elevance Health Inc Registered Shs: Bilanz (in Mio. USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 75’463 | 69’523 | 66’378 | 61’332 | 55’077 | 46’526 | 43’929 |
| Langzeit Gesamtverbindlichk. je Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 41’426 | 39’405 | 36’394 | 36’128 | 33’199 | 31’728 | 28’541 |
| Veränderung Eigenkapital in % | 5.11 | 8.26 | 0.68 | 8.62 | 4.64 | 11.17 | 7.69 |
| Bilanzsumme | 116’889 | 108’928 | 102’772 | 97’460 | 88’276 | 78’254 | 72’470 |
| Veränderung Bilanzsumme in % | 7.31 | 5.99 | 5.45 | 10.40 | 12.81 | 7.98 | 1.41 |
Elevance Health Inc Registered Shs: Sonstige Angaben (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 25.81 | 25.38 | 25.10 | 25.04 | 18.23 | 18.81 | 14.53 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 1.69 | 1.10 | 0.27 | 37.34 | -3.11 | 29.49 | -1.13 |
| Gewinn je Aktie (verwässert) | 25.68 | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 |
| Veränderung Gewinn je Aktie (verwässert) in % | 1.81 | 1.63 | 0.33 | 37.57 | -2.64 | 30.11 | -1.09 |
| Anzahl Mitarbeiter | 104’200 | 104’900 | 102’300 | 98’200 | 83’400 | 70’600 | 63’900 |
| Veränderung Anzahl Mitarbeiter in % | -0.67 | 2.54 | 4.18 | 17.75 | 18.13 | 10.49 | 14.11 |
Elevance Health Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Elevance Health Inc Registered Shs | Hauptversammlung | 14.05.2025 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 16.07.2025 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 15.10.2025 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 28.01.2026 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 22.04.2026 |
Elevance Health Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q1 2025 Earnings Release | 22.04.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 23.01.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 17.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 17.07.2024 |
| Hauptversammlung | Annual General Meeting | 15.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 18.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 24.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 18.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 19.07.2023 |
| Hauptversammlung | Annual General Meeting | 10.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 19.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 25.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 19.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 20.07.2022 |
| Hauptversammlung | Annual General Meeting | 18.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 20.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 26.01.2022 |
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 63’900 | 70’600 | 83’400 | 98’200 | 102’300 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1.44 | 1.48 | 1.46 | 1.41 | 1.53 |
Bilanz (in Mio. USD) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 34’321 | 39’033 | 45’751 | 51’122 | 55’617 |
| Summe Anlagevermögen | 38’149 | 39’221 | 42’525 | 46’338 | 47’155 |
| Summe Aktiva | 72’470 | 78’254 | 88’276 | 97’460 | 102’772 |
Bilanz (in Mio. USD) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 43’929 | 46’526 | 55’077 | 61’332 | 66’378 |
| Summe Eigenkapital | 28’541 | 31’728 | 33’199 | 36’128 | 36’394 |
| Summe Passiva | 72’470 | 78’254 | 88’276 | 97’460 | 102’772 |
Adresse
| 220 Virginia Avenue, 46204 Indianapolis | |
| Telefon | +1 (833) 401-1577 |
| URL | http://www.elevancehealth.com |
Management
|
Antonio Fabio Neri
Independent Director |
|
Bahija Jallal
Independent Director |
|
Blair W. Todt
Executive VP, Chief Legal & Administrative Officer |
|
Bryony Winn
President-Health Solutions |
|
Chris Rigg
Senior VP & CFO-Commercial & Specialty Business |
|
Deanna Dawnette Strable-Soethout
Independent Director |
|
Dustin Wilcox
Chief Information Security Officer |
|
Elizabeth E. Tallett
Independent Chairman |
|
Felicia Farr Norwood
President-Government Health Benefits & EVP |
|
Gail Koziara Boudreaux
President, Chief Executive Officer & Director |
|
Hakon Mattson
Chief Sustainability Officer |
|
Jill A. Becher
Vice President-Planning & Execution |
|
Kathleen S. Kiefer
Secretary & Chief Governance Officer |
|
Kyle Weber
Chief Strategy Officer |
|
Lewis Hay
Independent Director |
|
Marcus D. Wilson
Chief Analytics Officer |
|
Mark B. Kaye
Chief Financial Officer & Executive Vice President |
|
Morgan Kendrick
President-Commercial Health Benefits & EVP |
|
Nathan Rich
Vice President-Investor Relations |
|
Peter David Haytaian
Executive VP, President-Carelon & CarelonRX |
|
R. Kerry Clark
Independent Director |
|
Rachel Stuve
Sr. Director Data Science & AI |
|
Ramiro G. Peru
Independent Director |
|
Ratnakar Lavu
Chief Digital & Information Officer & Executive VP |
|
Robert L. Dixon
Independent Director |
|
Ronald William Penczek
Chief Accounting Officer & Controller |
|
Ryan M. Schneider
Independent Director |
|
Scott Towers
President-Dental Business |
|
Shantanu Agrawal
Chief Health Officer |
|
Susan D. DeVore
Independent Director |